These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 8617242)
1. The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors. Antinore MJ; Birrer MJ; Patel D; Nader L; McCance DJ EMBO J; 1996 Apr; 15(8):1950-60. PubMed ID: 8617242 [TBL] [Abstract][Full Text] [Related]
3. Interaction of the fork head domain transcription factor MPP2 with the human papilloma virus 16 E7 protein: enhancement of transformation and transactivation. Lüscher-Firzlaff JM; Westendorf JM; Zwicker J; Burkhardt H; Henriksson M; Müller R; Pirollet F; Lüscher B Oncogene; 1999 Oct; 18(41):5620-30. PubMed ID: 10523841 [TBL] [Abstract][Full Text] [Related]
4. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737 [TBL] [Abstract][Full Text] [Related]
5. Induction of pRb degradation by the human papillomavirus type 16 E7 protein is essential to efficiently overcome p16INK4a-imposed G1 cell cycle Arrest. Giarrè M; Caldeira S; Malanchi I; Ciccolini F; Leão MJ; Tommasino M J Virol; 2001 May; 75(10):4705-12. PubMed ID: 11312342 [TBL] [Abstract][Full Text] [Related]
6. Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes. Helt AM; Galloway DA J Virol; 2001 Aug; 75(15):6737-47. PubMed ID: 11435552 [TBL] [Abstract][Full Text] [Related]
7. Positive and negative regulation of cell proliferation by E2F-1: influence of protein level and human papillomavirus oncoproteins. Melillo RM; Helin K; Lowy DR; Schiller JT Mol Cell Biol; 1994 Dec; 14(12):8241-9. PubMed ID: 7969161 [TBL] [Abstract][Full Text] [Related]
8. Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells. Pagano M; Dürst M; Joswig S; Draetta G; Jansen-Dürr P Oncogene; 1992 Sep; 7(9):1681-6. PubMed ID: 1323816 [TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus type 16 E7 protein inhibits DNA binding by the retinoblastoma gene product. Stirdivant SM; Huber HE; Patrick DR; Defeo-Jones D; McAvoy EM; Garsky VM; Oliff A; Heimbrook DC Mol Cell Biol; 1992 May; 12(5):1905-14. PubMed ID: 1314947 [TBL] [Abstract][Full Text] [Related]
10. Identification of a novel retinoblastoma gene product binding site on human papillomavirus type 16 E7 protein. Patrick DR; Oliff A; Heimbrook DC J Biol Chem; 1994 Mar; 269(9):6842-50. PubMed ID: 8120046 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the binding of the human papillomavirus type 16 and cottontail rabbit papillomavirus E7 proteins to the retinoblastoma gene product. Haskell KM; Vuocolo GA; Defeo-Jones D; Jones RE; Ivey-Hoyle M J Gen Virol; 1993 Jan; 74 ( Pt 1)():115-9. PubMed ID: 8380832 [TBL] [Abstract][Full Text] [Related]
12. Estrogen contributes to non-pRb targeted HPV18 E7-caused cell proliferation and transformation. Yan X; Shah W; Li X; Wang Y Cancer Biol Ther; 2010 Feb; 9(3):206-15. PubMed ID: 20009582 [TBL] [Abstract][Full Text] [Related]
13. Recruitment of the retinoblastoma protein to c-Jun enhances transcription activity mediated through the AP-1 binding site. Nishitani J; Nishinaka T; Cheng CH; Rong W; Yokoyama KK; Chiu R J Biol Chem; 1999 Feb; 274(9):5454-61. PubMed ID: 10026157 [TBL] [Abstract][Full Text] [Related]
14. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent. Armstrong DJ; Roman A Virology; 1997 Dec; 239(1):238-46. PubMed ID: 9426463 [TBL] [Abstract][Full Text] [Related]
15. Interaction of the HPV E7 proteins with the pCAF acetyltransferase. Avvakumov N; Torchia J; Mymryk JS Oncogene; 2003 Jun; 22(25):3833-41. PubMed ID: 12813456 [TBL] [Abstract][Full Text] [Related]
16. Biological and biochemical activity of E7 genes of the cutaneous human papillomavirus type 5 and 8. Yamashita T; Segawa K; Fujinaga Y; Nishikawa T; Fujinaga K Oncogene; 1993 Sep; 8(9):2433-41. PubMed ID: 8395681 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1. Schmitt A; Harry JB; Rapp B; Wettstein FO; Iftner T J Virol; 1994 Nov; 68(11):7051-9. PubMed ID: 7933087 [TBL] [Abstract][Full Text] [Related]
18. Binding of the human papillomavirus type 16 E7 oncoprotein and the adeno-associated virus Rep78 major regulatory protein in vitro and in yeast and the potential for downstream effects. Hermonat PL; Santin AD; Zhan D J Hum Virol; 2000; 3(3):113-24. PubMed ID: 10881991 [TBL] [Abstract][Full Text] [Related]
19. Both of the N-terminal and C-terminal regions of human papillomavirus type 16 E7 are essential for immortalization of primary rat cells. Yamashita T; Segawa K; Jimbow K; Fujinaga K J Investig Dermatol Symp Proc; 2001 Nov; 6(1):69-75. PubMed ID: 11764290 [TBL] [Abstract][Full Text] [Related]
20. Chemical synthesis of human papillomavirus type 16 E7 oncoprotein: autonomous protein domains for induction of cellular DNA synthesis and for trans activation. Rawls JA; Pusztai R; Green M J Virol; 1990 Dec; 64(12):6121-9. PubMed ID: 2173783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]